Nektar Therapeutics
SEC CIK 906709 · NKTR · last insider filing 2026-06-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Robin Howard W | Director · President & CEO | filed 2007 - 2026 |
| Greer R Scott | Director | filed 2010 - 2025 |
| Chess Robert | Director · Executive Chairman | filed 2006 - 2025 |
| Ajer Jeffrey Robert | Director | filed 2017 - 2025 |
| Brainard Diana | Director | filed 2021 - 2025 |
| Whitfield ROY A | Director | filed 2006 - 2025 |
| Myriam Curet | Director | filed 2019 - 2023 |
| Eastham Karin | Director | filed 2018 - 2022 |
| Lingnau Lutz | Director | filed 2007 - 2020 |
| Kuebler Christopher A | Director | filed 2006 - 2018 |
| Winger Dennis L | Director | filed 2009 - 2018 |
| Krivulka Joseph J | Director | filed 2006 - 2017 |
| Wang Susan | Director | filed 2006 - 2015 |
| Brown Michael A/CA | Director | filed 2006 - 2009 |
| Lerner Irwin | Director | filed 2006 - 2008 |
| Huh Hoyoung | Director · Chief Operating Officer | filed 2007 - 2008 |
| Patton John Stuart | Director · Chief Scientific Officer | filed 2006 - 2008 |
| Gill Ajit | Director · President & CEO | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Zalevsky Jonathan | Chief R&D Officer | filed 2019 - 2026 |
| Rubinstein Linda M | Interim CFO | filed 2026 - 2026 |
| Wilson Mark Andrew | SVP & General Counsel | filed 2020 - 2025 |
| Gardiner Sandra A. | Chief Financial Officer | filed 2023 - 2023 |
| Thomsen Jillian B. | VP & Chief Accounting Officer | filed 2008 - 2023 |
| Labrucherie Gil M | SVP, COO & CFO | filed 2007 - 2022 |
| Northcott John | SVP & Chief Commercial Officer | filed 2019 - 2022 |
| Doberstein Stephen K | SVP & Chief Scientific Officer | filed 2010 - 2019 |
| Nicholson John | SVP & Chief Operating Officer | filed 2007 - 2019 |
| Hora Maninder | SVP Pharma Dev and Mfg | filed 2012 - 2019 |
| Gergel Ivan P. | SVP Drug Development & CMO | filed 2014 - 2017 |
| Medve Robert | SVP & Chief Medical Officer | filed 2012 - 2014 |
| Ghosh Rinko | SVP and Chief Business Officer | filed 2010 - 2013 |
| Lorianne Masuoka K. | SVP & Chief Medical Officer | filed 2009 - 2011 |
| Chowrira Bharat M | SVP & COO | filed 2008 - 2010 |
| Moreadith Randall W | SVP Drug Development | filed 2008 - 2009 |
| Elam Nevan C | VP, Pulmonary Business Unit | filed 2006 - 2008 |
| Harkness Timothy | SVP & Chief Financial Officer | filed 2007 - 2007 |
| Johnston David | SVP, Research & Development | filed 2006 - 2007 |
| Drapeau Louis | Sr. VP Finance, CFO | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.